First-of-its-kind PhD program in cancer engineering – MSKCC

Memorial Sloan Kettering Cancer Center (MSKCC) shared on LinkedIn: 

“Last fall, Memorial Sloan Kettering Cancer Center (MSK)’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) launched a first-of-its-kind PhD program in cancer engineering to enable aspiring scientists to tackle tough cancer problems.

Students in the program have unparalleled access to cutting-edge tools and have the opportunity to engineer brand new technologies to accelerate discovery.

MSK biomedical engineer Dan Heller and MSK biochemist and bioengineer Kayvan Keshari are eager to mentor students from a variety of backgrounds and disciplines, including engineering and the physical sciences.

‘In most institutions, you can develop amazing technologies but never translate your ideas,’ Dr. Keshari says. ‘At MSK, you might actually be able to do something that can change someone’s life.’

Learn more.”

Source: MSKCC/LinkedIn